Related Experiment Videos

Cardiac myosin: preparation, ATPase in chronic heart hypertrophy

Recent Advances in Studies on Cardiac Structure and Metabolism
|January 1, 1975
PubMed

Insights

Chronic heart failure in rabbits shows decreased myosin CaATPase activity. This defect in cardiac myosin function is linked to heart hypertrophy but its cause remains unclear, suggesting myosin abnormality.

Area of Science:

  • Biochemistry
  • Cardiovascular Physiology
  • Molecular Biology

Background:

  • Chronic heart hypertrophy is associated with reduced myofibrillar ATPase activity.
  • The underlying biochemical mechanisms of this cardiac defect are not fully understood.

Purpose of the Study:

  • To investigate the biochemical basis of decreased cardiac myosin ATPase activity in chronic aortic insufficiency (CAI).
  • To analyze the properties of myosin and its subunits in experimental heart hypertrophy.

Main Methods:

  • Studied three different preparations of heart myosin, assessing purity via MgATPase activity and polyacrylamide gel electrophoresis.
  • Measured heart myosin CaATPase activity at different ionic strengths (0.6 and 0.06) in rabbits with CAI.
  • Analyzed myosin light subunits using gel electrophoresis to determine molecular weight and charge.

Main Results:

  • Heart myosin CaATPase activity was significantly decreased in rabbits with CAI across all myosin preparations.
  • Analysis revealed normal charge and molecular weight for two light myosin subunits in CAI.
  • No evidence of myosin inhibitors or abnormalities in the nucleoprotein fraction was found.

Conclusions:

  • The study indicates that myosin itself is abnormal in chronic aortic insufficiency, leading to reduced CaATPase activity.
  • This myosin abnormality contributes to the pathogenesis of chronic heart hypertrophy.
  • Further research is needed to elucidate the precise molecular alterations in cardiac myosin.

Related Concept Videos